Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Tur

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2024
Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosisSara Collorone, Llucia Coll, Marco Lorenzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2016
Grey matter atrophy is associated with disability increase in natalizumab-treated patientsEthel Ciampi, Deborah Pareto, Jaume Sastre-Garriga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 22, 2024
The evolving contribution of MRI measures towards the prediction of secondary progressive multiple sclerosisPiriyankan Ananthavarathan, Nitin Sahi, Karen Chung, et al.
NPJ Digital Medicine|July 26, 2019
Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosisBaris Kanber, Parashkev Nachev, Frederik Barkhof, et al.
NPJ Digital Medicine|July 16, 2019
High-dimensional detection of imaging response to treatment in multiple sclerosisBaris Kanber, Parashkev Nachev, Frederik Barkhof, et al.
The Lancet Regional Health. Europe|October 24, 2024
Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseEmilio Portaccio, Melinda Magyari, Eva Kubala Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2022
<i>HLA-DRB1*1501</i> influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosisWallace J Brownlee, Carmen Tur, Andreea Manole, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2020
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosisRosa Cortese, Carmen Tur, Ferran Prados, et al.
Brain Communications|January 8, 2025
A data-driven model of disability progression in progressive multiple sclerosisSara Garbarino, Carmen Tur, Marco Lorenzi, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2024
Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosisSara Collorone, Llucia Coll, Marco Lorenzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2016
Grey matter atrophy is associated with disability increase in natalizumab-treated patientsEthel Ciampi, Deborah Pareto, Jaume Sastre-Garriga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 22, 2024
The evolving contribution of MRI measures towards the prediction of secondary progressive multiple sclerosisPiriyankan Ananthavarathan, Nitin Sahi, Karen Chung, et al.
NPJ Digital Medicine|July 26, 2019
Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosisBaris Kanber, Parashkev Nachev, Frederik Barkhof, et al.
NPJ Digital Medicine|July 16, 2019
High-dimensional detection of imaging response to treatment in multiple sclerosisBaris Kanber, Parashkev Nachev, Frederik Barkhof, et al.
The Lancet Regional Health. Europe|October 24, 2024
Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseEmilio Portaccio, Melinda Magyari, Eva Kubala Havrdova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 18, 2022
<i>HLA-DRB1*1501</i> influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosisWallace J Brownlee, Carmen Tur, Andreea Manole, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2020
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosisRosa Cortese, Carmen Tur, Ferran Prados, et al.
Brain Communications|January 8, 2025
A data-driven model of disability progression in progressive multiple sclerosisSara Garbarino, Carmen Tur, Marco Lorenzi, et al.
Pageof 15